This monumental achievement marks a significant milestone, as the brand can now touch the lives of countless mothers, spreading the gift of nourishment and love to millions
Nutrizoe unveils the clinical validation of its flagship product, Lactobites, a beacon of hope for new mothers, delivering remarkable results in enhancing breast milk supply. The clinical trials carried out under the esteemed Indian Council of Medical Research (ICMR), have been immortalised in the renowned Indian Journal of Obstetrics and Gynaecology Research (IJOGR). This monumental achievement marks a significant milestone, as the brand can now touch the lives of countless mothers, spreading the gift of nourishment and love to millions.
As a pioneer in maternal nutrition, Nutrizoe stands tall as India’s dedicated women-only nourishment brand, committed to nurturing the holistic health of mothers. Lactobites, lovingly crafted through a profound understanding of a mother’s needs, was launched in 2020 after extensive research that involved the participation of over 3,000 mothers. Entering the market with just two SKUs, this thoughtfully designed product embodies the heart and soul of Nutrizoe’s mission – to empower and elevate the well-being of mothers everywhere.
The clinical study called ‘the effect of lactobites bar as a galactagogue to Increase the production of Milk in lactating women and promote overall healthy recovery of lactating mothers,’ was conducted on over 100 mothers, making it a significant stride in maternal healthcare. Led by distinguished medical experts, including Dr Narendra Malhotra, former president of the Federation of Obstetric and Gynaecological Societies of India (FOGSI) and currently MD of Rainbow Children’s Hospital, Ujjal Cygnus, Agra, alongside Dr Nikhil Datar, Head of the Gynaecology Department at Cloud 9 Hospital, Mumbai, the trials are a testament to the product’s scientific rigour and credibility.